Cartalax

What Cartalax Is Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly, or "AEDG"). It was developed by Vladimir Khavinson, a Russian gerontologist and researcher who has created an entire family of short synthetic peptides — often called "Khavinson peptides" or peptide bioregulators — each theoretically targeted at a specific organ or tissue system. Cartalax is the one specifically designed and marketed for cartilage tissue. It's part of a broader product family that includes peptides like: Vladonix (immune system) Chonluten (bronchial/lung tissue) Svetinorm (liver) Pinealon (brain/pineal gland) Testoluten (testes/reproductive) Cartalax (cartilage) Each is marketed around Khavinson's theory that short peptides can act as tissue-specific "bioregulators." Proposed Mechanism of Action (Khavinson's Theory) The overarching concept behind Cartalax and the other Khavinson peptides is called "peptide bioregulation theory." According to this framework: Short peptides (2-4 amino acids) are proposed to penetrate the cell nucleus and bind to DNA They're theorized to help regulate gene expression and protein synthesis in a tissue-specific manner For Cartalax specifically, the claim is that it helps regulate genes involved in chondrocyte (cartilage cell) function, potentially supporting cartilage matrix production and slowing degenerative processes The broader theoretical framework suggests these peptides can help "restore" age-related declines in tissue-specific protein synthesis, tied into Khavinson's larger interest in aging and longevity science What Cartalax Is Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly, or "AEDG"). It was developed by Vladimir Khavinson, a Russian gerontologist and researcher who has created an entire family of short synthetic peptides — often called "Khavinson peptides" or peptide bioregulators — each theoretically targeted at a specific organ or tissue system. Cartalax is the one specifically designed and marketed for cartilage tissue. It's part of a broader product family that includes peptides like: Vladonix (immune system) Chonluten (bronchial/lung tissue) Svetinorm (liver) Pinealon (brain/pineal gland) Testoluten (testes/reproductive) Cartalax (cartilage) Each is marketed around Khavinson's theory that short peptides can act as tissue-specific "bioregulators." Proposed Mechanism of Action (Khavinson's Theory) The overarching concept behind Cartalax and the other Khavinson peptides is called "peptide bioregulation theory." According to this framework: Short peptides (2-4 amino acids) are proposed to penetrate the cell nucleus and bind to DNA They're theorized to help regulate gene expression and protein synthesis in a tissue-specific manner For Cartalax specifically, the claim is that it helps regulate genes involved in chondrocyte (cartilage cell) function, potentially supporting cartilage matrix production and slowing degenerative processes The broader theoretical framework suggests these peptides can help "restore" age-related declines in tissue-specific protein synthesis, tied into Khavinson's larger interest in aging and longevity science

Pairs well with